2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
349
Neoplasms
315
Carcinoma, Non-Small-Cell Lung
277
Prostatic Neoplasms
221
Colorectal Neoplasms
208
Lung Neoplasms
177
Multiple Myeloma
149
Ovarian Neoplasms
136
Pancreatic Neoplasms
130
Neoplasm Metastasis
123
Leukemia, Myeloid, Acute
121
Melanoma
104
Squamous Cell Carcinoma of Head and Neck
90
Recurrence
84
Lymphoma
84
Carcinoma, Renal Cell
84
Lymphoma, Non-Hodgkin
82
Endometrial Neoplasms
82
Stomach Neoplasms
80
Brain Neoplasms
80
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Carcinoma, Hepatocellular
77
Head and Neck Neoplasms
71
Glioma
70
Glioblastoma
70
Uterine Cervical Neoplasms
67
Urinary Bladder Neoplasms
65
Leukemia, Lymphocytic, Chronic, B-Cell
65
Sarcoma
63
Hematologic Neoplasms
62
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts